Data protection Impressum

Pharma

The partnership between Lonza and the HES-SO Valais-Wallis is yielding results

31 August 2021

Debiopharm launches IDEAL, a new hub for life sciences

17 August 2021

Women’s health biopharmaceutical company ObsEva receives USD 500 million

10 August 2021

GeNeuro raises EUR 6 million for multiple sclerosis treatment

21 July 2021

Pharmaplan opens a branch in Visp

21 June 2021

Lonza invests CHF 650 million in a new large-scale production facility in Visp

10 May 2021

Lonza invests CHF 200 million in a new production facility in Visp

27 April 2021

Lonza to create 1,200 new jobs at its Covid-19 vaccine production site in Visp

12 April 2021

Medtech company MedAlliance raises over USD 50 million to commercialize drug-eluting balloons

24 March 2021

Debiopharm enters EUR 900+ million contract with Merck

3 March 2021

1 … 9 10 11 12 13 14 15